All In Biotech

Free tool

FAERS Monitor: Lithobid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018027 or its brand name (Lithobid, Lithium Carbonate). Reports on generic versions are filed under their own applications.

Reports

16,978

Serious

13,565

80% of reports

Hospitalization

7,191

Death reported

1,226

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • toxicity to various agents1,252
  • drug ineffective1,156
  • tremor1,090
  • drug interaction1,015
  • nausea849
  • weight increased824
  • depression721
  • insomnia721
  • fatigue698
  • vomiting676
  • confusional state649
  • somnolence643
  • anxiety620
  • off label use603
  • suicide attempt590

Reports by year received

View as table
YearReports
2004576
2005495
2006795
20071,046
2008755
2009866
2010842
20111,140
20121,430
2013509
2014413
2015632
2016720
2017604
2018730
2019690
2020693
2021772
2022749
2023727
2024661
2025600
2026533

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,181 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
suicide attemptSignal59012.211.25,992
toxicity to various agentsSignal1,2529.38.89,220
tremorSignal1,0908.27.76,875
drug interactionSignal1,0158.07.56,188
confusional stateSignal6495.04.62,075
weight increasedSignal8244.64.32,312
somnolenceSignal6434.03.71,432
depressionSignal7213.93.71,588
insomniaSignal7213.43.11,205
anxietySignal6202.72.5671
vomiting6761.81.7236
nausea8491.31.272
fatigue6981.11.08
drug ineffective1,1561.11.08
off label use6030.90.816

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.